• S&P 500: 1,342.64
  • Change: -0.69%
$10.92 -0.21 (-1.89%)
2/10/2012 4:00 PM

Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

Current Price $10.92 Mkt Cap $1.05B
Open $11.02 P/E Ratio 0.00
Prev. Close $11.13 Div. (Yield) N/A (N/A)
Daily Range $10.75 - $11.08 Volume 1,568,468
52-Wk Range $2.67 - $15.25 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think IDIX will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

189 Outperform
43 Underperform
 

All-Star Players

52 Outperform
14 Underperform
 

Wall Street

3 Outperform
5 Underperform
 

Top IDIX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

darkflame (98.41)
Submitted April 15, 2007

What company is this ? Well...it's a small biotec company, Novartis owns more than 10% of it and isnt selling any shares. Novartis bought more than 4 million shares of IDIX at a price over 20 dollars per share. What's the price today ? About 7… More

3 Comments | Reply | Report this Post

zzlangerhans (99.27)
Submitted December 17, 2007

After the recent restructuring, it is now clear where this company stands. One HIV drug in phase I with no current plan for a phase II trial. One or two HCV drugs in preclinical development, with a history of one massive faceplant in HCV. Also a… More

2 Comments | Reply | Report this Post
IDIX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about IDIX.

Recs

0
Member Avatar sunnyspot (55.22) Submitted: 2/5/2012 12:46:17 PM : Underperform Start Price: $11.39 IDIX Score: +4.41

Despite strong growth in recent months, Gilead Sciences beat them to the punch on hepatitis C, upon which Idenix had hung its hopes. A rebound may take a while.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar getrichslowfool (52.89) Submitted: 1/13/2012 3:20:40 PM : Outperform Start Price: $14.76 IDIX Score: -30.40

It is going to get bought out, likely for more than the 2.5 billion or whatever INHX got. I'm thinking 30-35 bucks per share.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar geomedf (39.75) Submitted: 1/11/2012 2:03:45 AM : Outperform Start Price: $12.29 IDIX Score: -15.52

Wild card is IDIX over ACHN as only remaining Nuc therapy for hep C, as VRUS and INHS both were acquired at huge premium in this narrowed space competing to develop an all-oral hepatitis C therapy for this epidemic worldwide valued at as much as $3 billion. IDIX has broken out but expect it to run up significantly in the near term based on valuation, pipeline, short covers and new valuation of 18.

Report this Post 1 Comment | Reply | Permalink
View All 30 Pitches »

Leaderboard

Find the members with the highest scoring picks in IDIX.

Score Leader

tecno1

tecno1 (77.47) Score: +618.34

The Score Leader is the player with the highest score across all their picks in IDIX.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
portefeuille3 99.61 11/27/2009 Outperform 5Y $1.85 +490.27% +22.63% +467.64 0 Comment
Snoopdogg49r < 20 11/23/2009 Outperform 5Y $1.88 +480.85% +21.35% +459.50 0 Comment
kaiserball200 < 20 11/23/2009 Outperform 5Y $1.88 +480.85% +21.35% +459.50 0 Comment
sigeptrooper02 91.36 11/23/2009 Outperform 5Y $1.88 +480.85% +21.35% +459.50 1 Comment
rty168 73.02 11/25/2009 Outperform 5Y $1.94 +462.89% +21.04% +441.85 0 Comment
CallMeSmokinJoe 96.81 12/11/2009 Outperform 5Y $2.06 +430.10% +20.88% +409.21 0 Comment
ravihdesai 67.32 12/17/2009 Outperform 5Y $2.08 +426.27% +21.68% +404.58 0 Comment
Benitism 99.60 1/6/2010 Outperform 5Y $2.16 +405.56% +18.12% +387.43 0 Comment
mrwimbledon 88.03 9/12/2007 Outperform NS $2.61 +318.39% -4.28% +322.67 0 Comment
cschier < 20 8/13/2007 Outperform 5Y $2.66 +310.53% -3.45% +313.98 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackStifel 96.91 1/27/2012 Underperform NS $12.65 -14.23% +2.26% +16.48 0 Comment
TrackJMP 84.91 1/10/2012 Underperform NS $9.71 +11.74% +3.72% -8.02 0 Comment
TrackUltraLong 83.23 11/2/2011 Underperform NS $6.24 +73.88% +8.37% -65.50 1 Comment
TrackBreanMurray 66.37 6/2/2011 Underperform NS $4.52 +140.04% +1.70% -138.35 0 Comment
trackthinkequity 90.23 2/10/2011 Underperform NS $2.96 +266.55% +1.98% -264.58 0 Comment
TrackStifel 96.91 7/14/2010 Outperform NS $5.56 -46.76% +20.28% -67.04 2/10/2011 @ $2.96 0 Comment
TrackJMP 84.91 5/7/2010 Outperform NS $3.65 -13.97% +0.04% -14.01 9/8/2010 @ $3.14 0 Comment
TrackWedbush 84.91 10/21/2009 Outperform NS $2.90 +274.14% +23.07% +251.06 0 Comment
TrackTWeisel 91.94 6/12/2009 Outperform NS $3.55 +205.63% +43.64% +161.99 0 Comment
TrackJMP 84.91 3/13/2009 Outperform NS $2.96 +24.32% +25.35% -1.03 7/21/2009 @ $3.68 0 Comment
trackthinkequity 90.23 1/27/2009 Outperform NS $6.00 -50.67% +56.28% -106.95 2/10/2011 @ $2.96 0 Comment
TrackCarisandCo 88.67 4/21/2008 Outperform NS $6.25 +73.60% +0.62% +72.98 0 Comment
TrackEveillard 96.03 9/30/2007 Outperform NS $2.89 +73.70% -13.94% +87.64 3/31/2008 @ $5.02 1 Comment
TrackMorganJos 59.52 12/5/2006 Outperform NS $9.65 -25.18% +3.32% -28.50 4/13/2007 @ $7.22 0 Comment
TrackSusquehanna 78.08 11/21/2006 Outperform NS $8.96 -25.22% -1.29% -23.93 4/29/2008 @ $6.70 0 Comment
TrackMaximGroup < 20 8/24/2006 Outperform NS $8.75 -25.37% +15.74% -41.11 6/13/2007 @ $6.53 0 Comment

Featured Broker Partners